Argos Therapeutics (FRA:77AA) COGS-to-Revenue : 0.00 (As of Sep. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics COGS-to-Revenue?

Argos Therapeutics's Cost of Goods Sold for the three months ended in Sep. 2018 was €0.00 Mil. Its Revenue for the three months ended in Sep. 2018 was €1.07 Mil.

Argos Therapeutics's COGS to Revenue for the three months ended in Sep. 2018 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Argos Therapeutics's Gross Margin % for the three months ended in Sep. 2018 was N/A%.

Argos Therapeutics COGS-to-Revenue Historical Data

The historical data trend for Argos Therapeutics's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics COGS-to-Revenue Chart

Argos Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

COGS-to-Revenue

Get a 7-Day Free Trial

Argos Therapeutics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Argos Therapeutics COGS-to-Revenue Calculation

Argos Therapeutics's COGS to Revenue for the fiscal year that ended in Dec. 2017 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	1.605
	=	0.00

Argos Therapeutics's COGS to Revenue for the quarter that ended in Sep. 2018 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	1.069
	=	0.00

Argos Therapeutics (FRA:77AA) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Argos Therapeutics's Gross Margin % for the three months ended in Sep. 2018 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 1.069
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Argos Therapeutics COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Argos Therapeutics's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Argos Therapeutics (FRA:77AA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

4233 Technology Drive, Durham, NC, USA, 27704

Website

http://www.argostherapeutics.com

Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines